%0 Journal Article
%T Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH
%A Amelia Mitchell-Gears
%A David M. Knipe
%A Hee-Jin Jeong
%A Hidde L. Ploegh
%A Jessica R. Ingram
%A Kevin Zhangxu
%A Lestat R. Ali
%A Md Aladdin Bhuiyan
%A Michael Dougan
%A Michael J. Walsh
%A Patrick T. Bruck
%A Stephanie J. Crowley
%A Stephanie K. Dougan
%J -
%D 2020
%R 10.1098/rsob.190235
%X Cancer-specific mutations can lead to peptides of unique sequence presented on MHC class I to CD8 T cells. These neoantigens can be potent tumour-rejection antigens, appear to be the driving force ..
%U https://royalsocietypublishing.org/doi/10.1098/rsob.190235